Hani cofounded Lumere in 2012. He provides strategic vision for the company and advises health system executives on how to achieve the best clinical outcomes at an optimal cost. Under his leadership, Lumere was named “one of 50 startups to watch in 2017” by Built in Chicago.
Hani is a frequent presenter and panelist on topics including evidence-based care, healthcare disruption, physician engagement, process improvement and spend management. He previously served as a consultant in McKinsey & Company’s healthcare practice, where he helped found the firm’s health economics think tank, the Center for US Health System Reform.
Hani holds BA, JD and MPH degrees from Harvard University and was a Paul & Daisy Soros Fellow.
10 – Expediting Mergers & Acquisitions: The Role of Data and Clinical Evidence (Strategy, Financial; Course Level-Intermediate)
The healthcare industry has experienced a frenzy of merger and acquisition (M&A) activity in recent years which continues to remain steady. While mergers come with the promise of eliminating inefficiencies and benefiting from scale, the path is often complex. In fact, research has shown that hospitals often fail to realize cost synergies. Bon Secours and Mercy Health were committed to producing a different result.
Attend this session to learn how these organizations jointly leveraged clinical evidence and analytics to accelerate the benefits of their merger. To do so, they built an organizational framework to quickly scale and align their value analysis and vendor management capabilities. The result has been astounding, identifying savings of more than $48.9M in supply-related costs and achieving standardization in several clinical practices in less than two years.
Learn from these two presenters with a diverse range of clinical and operational experience. Amy Whitaker, RN, is the Vice President of Supply Chain Clinical Integration Accountability for all clinical integration activities within the organization while Hani Elias, JD, MPH, CEO of Lumere, provides strategic vision and advises health system executives on how to achieve the best clinical outcomes at an optimal cost.